Moderated by Axios, panelists discussed the promise of these therapies, the risks and regulatory challenges surrounding non-FDA-approved compounded versions, and what the next phase could mean for patients, providers, policymakers, and industry
For those days, keep a freezer stocked with GLP-1 friendly options
This process provides anti-aging benefits
Because the moment they proved it worked, every grey-market lab on earth would sell the exact same molecule, at a fraction of the price, having spent nothing
Batch consistency: Both peptides come from the same production batch, which supports reproducibility across multiple experiments